Supriya Lifescience

678.00
-12.35
(-1.79%)
Market Cap (₹ Cr.)
₹5,546
52 Week High
704.00
Book Value
₹
52 Week Low
239.80
PE Ratio
35.21
PB Ratio
6.12
PE for Sector
37.21
PB for Sector
3.95
ROE
12.85 %
ROCE
19.87 %
Dividend Yield
0.12 %
EPS
₹16.80
Industry
Pharmaceuticals
Sector
Pharmaceuticals - Indian - Bulk Drugs & Formln
comparison:

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Growth Rate
Revenue Growth
23.51 %
Net Income Growth
32.56 %
Cash Flow Change
78.13 %
ROE
13.72 %
ROCE
-9.99 %
EBITDA Margin (Avg.)
7.43 %

Financial Results

Quarterly Financials
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Revenue
85
134
79
151
122
185
104
115
108
144
135
143
143
160
163
169
Expenses
55
65
61
70
79
106
70
84
91
87
88
108
99
103
98
101
EBITDA
30
69
17
81
44
79
34
31
17
57
47
34
45
58
65
67
Operating Profit %
32 %
51 %
20 %
53 %
33 %
42 %
31 %
25 %
13 %
39 %
34 %
23 %
30 %
35 %
39 %
39 %
Depreciation
5
2
2
2
3
3
3
3
3
3
4
4
4
4
5
5
Interest
1
1
1
1
1
1
1
1
1
1
1
0
0
1
0
0
Profit Before Tax
25
66
14
78
40
75
30
27
13
53
43
30
40
53
60
62
Tax
9
17
2
20
12
18
5
10
2
13
10
9
10
9
15
15
Net Profit
16
49
8
58
40
46
25
17
10
38
29
24
30
37
45
46
EPS in ₹
2.14
6.63
0.96
7.96
4.93
5.74
3.14
2.10
1.18
4.75
3.54
2.97
3.70
4.59
5.54
5.71

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Total Assets
176
231
241
245
253
336
445
735
820
921
Fixed Assets
61
75
89
91
85
99
100
190
262
310
Current Assets
103
129
115
120
133
196
265
498
465
398
Capital Work in Progress
11
25
36
34
35
40
79
43
68
149
Investments
0
0
0
0
0
0
0
0
25
64
Other Assets
103
131
117
120
133
197
267
502
466
398
Total Liabilities
138
189
195
191
159
187
177
119
121
106
Current Liabilities
115
150
144
146
135
155
146
100
96
77
Non Current Liabilities
23
39
51
45
24
32
31
19
25
29
Total Equity
37
42
46
55
94
149
269
616
699
815
Reserve & Surplus
33
27
31
40
79
134
254
600
683
799
Share Capital
5
15
15
15
15
15
15
16
16
16

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
1
2
-2
3
4
62
15
139
-70
-83
Investing Activities
-23
-33
-27
-5
5
-25
-47
-60
-124
-174
Operating Activities
-6
14
27
28
49
117
76
49
64
113
Financing Activities
30
21
-2
-20
-50
-29
-15
150
-10
-22

Share Holding

% Holding
May 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Promoter
99.98 %
68.24 %
68.24 %
68.24 %
68.24 %
68.24 %
68.28 %
68.30 %
68.30 %
68.30 %
68.30 %
68.30 %
68.30 %
FIIs
0.00 %
10.30 %
7.13 %
5.99 %
6.79 %
6.24 %
5.65 %
5.73 %
5.34 %
4.56 %
5.36 %
4.95 %
6.03 %
DIIs
0.02 %
7.90 %
7.73 %
10.33 %
8.88 %
7.89 %
7.65 %
7.55 %
7.17 %
5.39 %
5.30 %
5.48 %
5.45 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
0.00 %
13.56 %
16.90 %
15.44 %
16.09 %
17.63 %
18.42 %
18.43 %
19.19 %
21.76 %
21.04 %
21.27 %
20.23 %

Dividend History

No dividends have been distributed by the company in the past 10 years

Peer Comparison Compare Peers on Screener

Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
1,768.40 4,25,929.94 38.00 49,887.17 12.06 9,648 27.35 40.28
1,461.45 1,18,825.56 25.74 26,520.66 14.17 4,155 12.95 38.47
2,526.90 1,02,885.42 48.65 10,615.63 19.57 1,942 28.89 46.80
1,193.00 1,01,290.13 18.97 28,905.40 12.36 5,578 -9.47 32.64
943.25 95,280.30 22.27 19,831.50 13.82 3,831 14.57 32.02
2,041.10 92,929.19 35.38 20,141.50 19.94 1,936 73.52 37.01
1,219.55 73,119.28 20.05 29,559.25 17.55 3,169 8.65 20.74
5,584.80 66,062.65 30.38 12,978.42 9.84 1,811 14.16 35.74
1,465.50 42,112.35 - 12,653.09 6.58 -1,831 675.84 30.08
1,570.00 39,910.21 59.43 7,829.81 22.92 529 80.05 52.38

Corporate Action

Technical Indicators

RSI(14)
Neutral
66.56
ATR(14)
Volatile
33.84
STOCH(9,6)
Neutral
47.74
STOCH RSI(14)
Neutral
60.27
MACD(12,26)
Bullish
4.35
ADX(14)
Weak Trend
24.57
UO(9)
Bearish
53.42
ROC(12)
Uptrend And Accelerating
10.39
WillR(14)
Overbought
-9.77